Conmed (CNMD) EBT Growth (1y) (2011 - 2026)
Conmed (CNMD) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 54.33% |
| 10 | Conmed | 994.72 Mn | 959.69 Mn | 183.45 Mn | 139.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.25% |
| Dec 31, 2025 | -32.97% |
| Sep 30, 2025 | -92.43% |
| Jun 30, 2025 | -20.25% |
| Mar 31, 2025 | -69.82% |
| Dec 31, 2024 | 7.27% |
| Sep 30, 2024 | 178.36% |
| Jun 30, 2024 | 115.34% |
| Mar 31, 2024 | 940.06% |
| Dec 31, 2023 | 486.06% |
| Sep 30, 2023 | 29.08% |
| Jun 30, 2023 | 118.64% |
| Mar 31, 2023 | -85.99% |
| Dec 31, 2022 | -135.54% |
| Sep 30, 2022 | -9.90% |
| Jun 30, 2022 | -673.96% |
| Mar 31, 2022 | 79.28% |
| Dec 31, 2021 | 119.65% |
| Sep 30, 2021 | 0.51% |
| Jun 30, 2021 | 149.75% |